Demographic and epidemiologic drivers of global cardiovascular mortality
- PMID: 25830423
- PMCID: PMC4482354
- DOI: 10.1056/NEJMoa1406656
Demographic and epidemiologic drivers of global cardiovascular mortality
Abstract
Background: Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease.
Methods: We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined.
Results: Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere.
Conclusions: The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces. (Funded by the Bill and Melinda Gates Foundation and others.).
Figures
Similar articles
-
The burden of disease among the global poor.Lancet. 1999 Aug 14;354(9178):586-9. doi: 10.1016/S0140-6736(99)02108-X. Lancet. 1999. PMID: 10470717
-
Estimates of global and regional premature cardiovascular mortality in 2025.Circulation. 2015 Sep 29;132(13):1270-82. doi: 10.1161/CIRCULATIONAHA.115.016021. Circulation. 2015. PMID: 26408271
-
[Epidemiological transition in Latin America: a comparison of four countries].Rev Med Chil. 1997 Jun;125(6):719-27. Rev Med Chil. 1997. PMID: 9580335 Spanish.
-
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease.Arch Med Res. 2015 Jul;46(5):328-38. doi: 10.1016/j.arcmed.2015.06.006. Epub 2015 Jun 29. Arch Med Res. 2015. PMID: 26135634 Review.
-
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.Eur Heart J. 2010 Mar;31(6):642-8. doi: 10.1093/eurheartj/ehq030. Epub 2010 Feb 22. Eur Heart J. 2010. PMID: 20176800 Review.
Cited by
-
Glucose-lowering medications and glucose levels as the major determinants of progression of carotid atherosclerosis in middle-aged adults and elders: a community-based prospective study.Front Endocrinol (Lausanne). 2024 Oct 18;15:1425027. doi: 10.3389/fendo.2024.1425027. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39493773 Free PMC article.
-
Development and Worsening of Hypertension with Age in Male Wistar Rats as a Physiological Model of Age-Related Hypertension: Correction of Hypertension with Taxifolin.Int J Mol Sci. 2024 Oct 18;25(20):11216. doi: 10.3390/ijms252011216. Int J Mol Sci. 2024. PMID: 39456996 Free PMC article.
-
Brevianamide F Exerts Antithrombotic Effects by Modulating the MAPK Signaling Pathway and Coagulation Cascade.Mar Drugs. 2024 Sep 26;22(10):439. doi: 10.3390/md22100439. Mar Drugs. 2024. PMID: 39452847 Free PMC article.
-
Can we stop the stroke tsunami? Mitigating the barriers, amplifying the facilitators.J R Soc N Z. 2020 Aug 4;52(2):109-128. doi: 10.1080/03036758.2020.1798477. eCollection 2022. J R Soc N Z. 2020. PMID: 39439818 Free PMC article. Review.
-
Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms.Front Endocrinol (Lausanne). 2024 Sep 30;15:1366285. doi: 10.3389/fendo.2024.1366285. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39403576 Free PMC article. Review.
References
-
- Beaglehole R, Bonita R, Horton R, et al. Measuring progress on NCDs: one goal and five targets. Lancet. 2012;380:1283–5. - PubMed
-
- A comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; Jul, 2012. http://who.int/nmh/events/2012/discussion_paper3.pdf.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical